Harvard Business Review

MARCH 9, 2015

Rather than be paralyzed by fear about who has access to what, savvy leaders recognize that information can empower employees to move the business closer to customers, that decision-making can be accelerated when vital data is not held hostage (or lost) and that visible conversations can prevent wasted effort and even spark innovation.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

DECEMBER 14, 2015

They want to see how these approaches … are truly beneficial to existing priorities like retention, talent advancement, innovation.” Chirag Patel, CEO of Amneal Pharmaceuticals and Ernst & Young 2011 Entrepreneur of the Year, credits meditation with helping him feel more connected to his clients.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

NOVEMBER 6, 2015

Many of the things we need to know to be successful – to innovate, collaborate, solve problems, and identify new opportunities – aren’t learned simply through schooling, training, or personal experience.

Company 8

Company Licensing Knowledge Management Transportation 8

Harvard Business Review

NOVEMBER 20, 2015

Here is some advice on how to tap into supply chains for successful scale-up: Reveal more than is comfortable. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

JUNE 23, 2015

I studied cross-functional teams in industries including communications, software, pharmaceuticals, semiconductors, agricultural, chemical, manufacturers, retail, utility, consulting, internet software, government, insurance, and banking. Cross-functional teams have become ubiquitous because companies need to speed innovations to market.

Team 8

Team Project Software Engineering 8

Harvard Business Review

DECEMBER 19, 2014

As two of his business units were completing their merger, Peter Noll, chief of the Diagnostics division at the Frankfurt-based Scherr Pharmaceuticals, felt it was time to address a nagging issue: The combined entity had no overarching revenue model. “We’ve found that our salespeople don’t like to sell services.

Case Study 10

Case Study Price Chemicals Strategy 10

Harvard Business Review

SEPTEMBER 11, 2014

Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. In other words, if you are in a high uncertainty industry, you must excel at innovation…or die. Customers Innovation Technology'

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

FEBRUARY 24, 2017

Holding up a bill in committee or working with others to stall legislation may be difficult to tie to any single person, while other actions can be defended on alternative premises , like coincidence (the idea that conflicts are inevitable among the myriad issues facing Congress) or even that they are based on a stockbroker’s advice.

Conflict of Interest 8

Conflict of Interest Committee Collins Politics 8